Novavax Inc (NVAX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$6.90
Buy
$6.91
$0.95 (+15.97%)
Prices updated at 08 May 2025, 15:05 EDT
| Prices minimum 15 mins delay
Prices in USD
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$7.50 - $6.48 | |
$23.86 - $4.43 | |
- | |
983.15m | |
- | |
- | |
19,649,273 | |
- | |
8,350,096.94 | |
2.90 | |
161.94m | |
US6700024010 | |
-1.23 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.